VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
VTAE was delisted on the 24th of October, 2016.
70 hedge funds and large institutions have $155M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 7 closing their positions.
243% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 7
53% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 15
32% more funds holding
Funds holding: 53 → 70 (+17)
19% less capital invested
Capital invested by funds: $193M → $155M (-$37.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$8.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.32M |
| 3 |
O
OrbiMed
New York
|
+$3.84M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$3.41M |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$37.6M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$1.31M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$880K |
| 4 |
TAF
Tredje AP-fonden
Se-111 91 Stockholm,
Sweden
|
-$848K |
| 5 |
AIC
AWM Investment Company
New York
|
-$812K |
VTAE Hedge Fund Activity: Q3 2015 in Review
70 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q3 2015, worth a combined $155M — down 19% from $193M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new VTAE positions and 7 closed out — a net gain of 17 holders — while 23 added to existing stakes and 15 trimmed.
The largest buyer was BVF Inc, adding an estimated $8.2M. The largest seller was NEA Management Company, exiting entirely with an estimated $37.6M sold.
- 70 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q3 2015, up from 53 in Q2 2015.
- Funds reported $155M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q3 2015, down 19% quarter-over-quarter.
- 24 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q3 2015 and 7 closed out, a net change of +17 holders.
- The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q3 2015 was BVF Inc, an estimated $8.2M added.
- The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q3 2015 was NEA Management Company, an estimated $37.6M sold.
Based on aggregated 13F filings for Q3 2015.